Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The company is headquartered in South San Francisco, California and currently employs 8 full-time employees. The company went IPO on 2014-10-02. The firm is winding up its operations. The firm is seeking to sell all of its clinical assets and programs. The firm has not generated any revenue.
Follow-Up Questions
Calithera Biosciences Inc (CALA) 的市盈率是多少？
Calithera Biosciences Inc 的市盈率是 0
Calithera Biosciences Inc 的 CEO 是谁？
Dr. Susan Molineaux 是 Calithera Biosciences Inc 的 President，自 2010 加入公司。
CALA 股票的价格表现如何？
CALA 的当前价格为 $0.0001，在上个交易日 decreased 了 0%。
Calithera Biosciences Inc 的主要业务主题或行业是什么？
Calithera Biosciences Inc 属于 Biotechnology 行业，该板块是 Health Care
